NHO Microbleeds in relationship to antithrombotic agents study

NHO Microbleeds in relationship to antithrombotic agents study - NOBLESSE study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030332

Enrollment

1200

Registered

2017-12-10

Start date

2017-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Ischemic stroke patients who take antithrombotic agent within three months of the ischemic stroke onset (2) 20 years and over at the time of entry (3) Male and Female (4) Patients who are able to receive MRI (5) Patients who are able to visit the hospital one year later (6) Provision of written informed consent

Exclusion criteria

Exclusion criteria: (1) Patients who have a plan to stop antithrombotic agent (2) Patients who have a plan to implant medical device not permitted at MRI examination. (3) Patients who cannot take MRI one year later (4) Patients that the doctor in charge judge not to be appropriate for participation in this study

Design outcomes

Primary

Measure	Time frame
Numbers of cerebral microbleeds signal on T2*-weighted gradient-echo	—

Countries

Japan

Contacts

Public ContactAsako Nakamura

National Hospital Organization Kyushu Medical Center Department of Cerebrovascular Medicine and Neurology

asakoro1012@yahoo.co.jp092-852-0700

Outcome results